Literature DB >> 19861384

Heart failure burden and therapy.

Faiez Zannad1, Nelly Agrinier, François Alla.   

Abstract

Heart failure (HF) is a syndrome with a broad spectrum of heterogeneous symptoms and signs resulting in a wide range of clinical expressions. The prevalence of HF is estimated to be 1-2% in developed countries, increasing with age. Heart failure is the leading cause of hospitalization for patients older than 65 years, raising concerns about the economic burden of this syndrome. This article provides a critical review of epidemiological and clinical aspects for HF; causes, comorbidities, and types of HF are also described. The systolic vs. diastolic, the acute vs. chronic approaches, and the connections between HF and left bundle branch block or atrial fibrillation are further detailed. In addition, a synthesis of the latest results and recommendations concerning the indication and the prescription of pharmacological (such as diuretics or rennin-angiotensin-aldosterone system inhibitors) and non-pharmacological treatments (particularly device therapy) is proposed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19861384     DOI: 10.1093/europace/eup304

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  24 in total

1.  Effect of omega-3 on brain natriuretic peptide and echocardiographic findings in heart failure: Double-blind placebo-controlled randomized trial.

Authors:  J Kojuri; M A Ostovan; G R Rezaian; P Archin Dialameh; N Zamiri; M B Sharifkazemi; M Jannati
Journal:  J Cardiovasc Dis Res       Date:  2013-02-27

Review 2.  Heart failure with preserved ejection fraction in the elderly: scope of the problem.

Authors:  Ken Kaila; Mark J Haykowsky; Richard B Thompson; D Ian Paterson
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 3.  Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes.

Authors:  Andrew P Ambrosy; Mihai Gheorghiade; Ovidiu Chioncel; Robert J Mentz; Javed Butler
Journal:  Curr Heart Fail Rep       Date:  2014-12

4.  Surgical ventricular reconstruction for ischaemic heart failure: state of the art.

Authors:  Serenella Castelvecchio; Andrea Garatti; Pier Vincenzo Gagliardotto; Lorenzo Menicanti
Journal:  Eur Heart J Suppl       Date:  2016-04-29       Impact factor: 1.803

5.  Analyses of drugs stored at home by elderly patients with chronic heart failure.

Authors:  Sebastian Ewen; Tanja Baumgarten; Volker Rettig-Ewen; Felix Mahfoud; Nina Griese-Mammen; Martin Schulz; Michael Böhm; Ulrich Laufs
Journal:  Clin Res Cardiol       Date:  2014-11-06       Impact factor: 5.460

6.  Deciphering STAT3 signaling in the heart: plasticity and vascular inflammation.

Authors:  Mazen Kurdi; George W Booz
Journal:  Congest Heart Fail       Date:  2010 Sep-Oct

Review 7.  Epidemiology and aetiology of heart failure.

Authors:  Boback Ziaeian; Gregg C Fonarow
Journal:  Nat Rev Cardiol       Date:  2016-03-03       Impact factor: 32.419

8.  Pre-Conditioning Stem Cells in a Biomimetic Environment for Enhanced Cardiac Tissue Repair: In Vitro and In Vivo Analysis.

Authors:  Aparna R Chakravarti; Settimio Pacelli; Perwez Alam; Samik Bagchi; Saman Modaresi; Andras Czirok; Rafeeq P H Ahmed; Arghya Paul
Journal:  Cell Mol Bioeng       Date:  2018-07-26       Impact factor: 2.321

9.  The prevalence and management of heart failure in Dutch nursing homes; design of a multi-centre cross-sectional study.

Authors:  Mariëlle Amj Daamen; Jan P H Hamers; Anton P M Gorgels; Hans-Peter Brunner-la Rocca; Frans E S Tan; Marja P van Dieijen-Visser; Jos M G A Schols
Journal:  BMC Geriatr       Date:  2012-06-11       Impact factor: 3.921

10.  Perindopril treatment promote left ventricle remodeling in patients with heart failure screened positive for autoantibodies against angiotensin II type 1 receptor.

Authors:  Qian Du; Jinling Wu; Hua Wang; Xin Wang; Lin Xu; Zhiyong Zhang; Jiamei Liu; Juan Zhang; Jin Chen; Hakon Hakonarson; Aihua Hu; Lin Zhang
Journal:  BMC Cardiovasc Disord       Date:  2013-10-31       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.